Klaus Überla

Klaus Überla publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Klaus Überla sits on this spectrum.

Klaus Überla D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Klaus Überla sits on this spectrum.

Best Publications

• Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern

  Unknown

  471
  Citations

• Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis

  Narges Tajik;Michael Frech;Oscar Schulz;Fabian Schälter

  442
  Citations

• Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.

  Thomas Blankenstein;Zheng Hong Qin;K Uberla;Werner Muller

  413
  Citations

• Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination

  Unknown

  329
  Citations

• S Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Mediates Entry into Hepatoma Cell Lines and Is Targeted by Neutralizing Antibodies in Infected Patients

  Heike Hofmann;Kim Hattermann;Andrea Marzi;Thomas Gramberg

  265
  Citations

• The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells

  Godwin Nchinda;Janelle Kuroiwa;Margarita Oks;Christine Trumpfheller

  252
  Citations

• Detection of human viruses in rivers of a densly-populated area in Germany using a virus adsorption elution method optimized for PCR analyses.

  Ibrahim Ahmed Hamza;Lars Jurzik;Alexander Stang;Klaus Sure

  240
  Citations

• Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques

  Christiane Stahl-Hennig;Martin Eisenblätter;Edith Jasny;Tamara Rzehak

  224
  Citations

• Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus : Implications for the safety of lentiviral vectors

  Ralf Wagner;Marcus Graf;Kurt Bieler;Hans Wolf

  224
  Citations

• Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies.

  Seraphin Kuate;Jindrich Cinatl;Hans Wilhelm Doerr;Klaus Überla

  215
  Citations

• Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization.

  Dennis Lapuente;Jana Fuchs;Jonas Willar;Ana Vieira Antão

  210
  Citations

• Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors.

  K Uberla;C Stahl-Hennig;D Böttiger;K Mätz-Rensing

  199
  Citations

• A Pathogenic Threshold of Virus Load Defined in Simian Immunodeficiency Virus- or Simian-Human Immunodeficiency Virus-Infected Macaques

  Peter Ten Haaft;Babs Verstrepen;Klaus Überla;Brigitte Rosenwirth

  192
  Citations

• Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction

  Cornelia Platzer;Günther Richter;Klaus Überla;Werner Müller

  187
  Citations

• Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzündlichen Erkrankungen und unter immunmodulatorischer Therapie.

  Norbert Wagner;Frauke Assmus;Gabriele Arendt;Erika Baum

  176
  Citations

• Methods to detect infectious human enteric viruses in environmental water samples

  Ibrahim Ahmed Hamza;Lars Jurzik;Klaus Überla;Michael Wilhelm

  169
  Citations

• Vaccinations with Tumor Cells Genetically Engineered to Produce Different Cytokines: Effectivity not Superior to a Classical Adjuvant

  Hanno Hock;Marion Dorsch;Ulrich Kunzendorf;Klaus Überla

  164
  Citations

• Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus.

  Tanja Schnell;Paul Foley;Melanie Wirth;Jan Munch

  162
  Citations

• Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides.

  Lars Steinstraesser;Bettina Tippler;Janine Mertens;Evert Lamme

  153
  Citations

• Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2.

  Matthias Tenbusch;Sofie Schumacher;Emanuel Vogel;Alina Priller

  114
  Citations